Last updated: August 11, 2025
Introduction
Patent KR20180122483 pertains to a pharmaceutical invention filed within South Korea's intellectual property framework, likely related to a novel drug, formulation, or therapeutic method. Analyzing its scope, claims, and the associated patent landscape provides critical insights for industry stakeholders, including pharmaceutical companies, investors, and legal professionals. This report dissects the patent's technical breadth and position within the broader innovation ecosystem.
Patent Overview
KR20180122483 was granted or published as a Korean patent application. Although the specific title is not provided, the patent’s identification number suggests a 2018 filing, aligning with the publication or grant year.
The core purpose of the patent appears centered on a pharmaceutical composition or method for treating a specific condition, potentially involving a novel active ingredient, delivery system, or combination therapy. Given this context, the patent's scope is likely tailored to safeguard inventive steps around drug efficacy, stability, or manufacturing process.
Scope and Detailed Claims Analysis
Claims Structure
Patents in the pharmaceutical domain typically contain multiple claims categorized into independent and dependent claims. Independent claims set the broadest protection, establishing the inventive core, while dependent claims detail specific embodiments or variations.
Key Elements of the Claims
Based on the typical structure and available patent data, the claims for KR20180122483 comprise:
-
Independent Claims: Likely covering a pharmaceutical composition comprising a novel active ingredient or a specific combination, possibly including delivery means, formulation specifics, or a method of manufacturing.
-
Dependent Claims: Narrower claims that specify patentable features such as particular dosage forms, concentrations, stabilizing agents, or methods of use.
Major Technical Aspects
1. Composition Specifics
Most pharmaceutical patents focus on a composition that provides enhanced bioavailability, stability, or therapeutic efficacy. KR20180122483 likely claims a unique formulation—possibly involving a novel compound, a drug carrier, or a combination of agents—that offers patentable advantages over existing therapies.
2. Method of Use or Manufacturing
Additional claims may cover methods of preparing the composition, optimizing dosing, or administering the drug to patients. Such claims broaden the scope to include processes and methods, which are crucial in pharmaceutical patent protection.
3. Therapeutic Indication
The patent might specify a treatment application for a specific disease, e.g., cancer, neurodegenerative conditions, or infectious diseases, which influences claim scope by tying the invention to therapeutic efficacy.
Claim Language and Scope
The scope's breadth depends on claim language; broader claims may encompass multiple variants, but risk validity issues if overly vague. Precise language, including parameters such as concentration ranges, molecular structures, and formulation conditions, ensures enforceability.
Patent Landscape Context
1. Korean Patent Environment
South Korea maintains a robust patent framework governed by the Korean Intellectual Property Office (KIPO). The patent system emphasizes clarity and scope, especially for pharmaceutical inventions, and aligns with global standards (e.g., Patent Cooperation Treaty, PCT).
2. Prior Art and Patent Family
KR20180122483 exists within a landscape featuring both domestic and international related patents. Several prior art documents—potentially including Korean, US, or European patents—detail similar compounds, formulations, or methods, which could impact the patent’s novelty and inventive step.
The patent family might include corresponding filings in other jurisdictions, which collectively establish territorial breadth and strategic protection.
3. Competitive Patent Landscape
The patent landscape likely involves key players such as multinational pharmaceutical companies and innovative biotech firms. KR20180122483 may face potential challenges concerning overlapping claims, especially if similar active compounds or formulations are disclosed elsewhere.
4. Patent Citations and Litigation Trends
Analyzing patent citations reveals how the patent interacts with existing technology. Forward citations indicate technological influence, while backward citations cite prior art that the patent distinguishes itself from. Litigation trends and patent oppositions—if any—offer additional context regarding the patent's robustness and market significance.
Strengths and Weaknesses of the Patent
Strengths:
- Broad Claim Scope: If independent claims encompass a wide range of compositions or uses, it secures extensive market exclusivity.
- Method Claims: Covering manufacturing or therapeutic methods enhances patent longevity and strategic value.
- Specificity: Claims with precise molecular or formulation parameters reduce infringement ambiguity and increase defensibility.
Weaknesses:
- Limited Specificity: Overly broad claims can be challenged on grounds of lack of novelty or inventive step.
- Prior Art Similarities: If existing compounds or methods are similar, the patent’s novelty could be questioned.
- Claim Drafting: Vague or ambiguous claim language may weaken enforceability.
Strategic Implications for Stakeholders
- Pharmaceutical Innovators: The patent's claims can be critical in designing robust product pipelines and defending market share.
- Legal Professionals: Need to monitor potential infringement and challenge opportunities, especially if the claims are broad.
- Investors: Patent strength and scope directly influence valuation, licensing potential, and exit strategies.
Conclusion
Patent KR20180122483 encapsulates a strategic inventive step in South Korea's pharmaceutical patent landscape. Its scope depends significantly on the granularity of its claims, which bridge broad therapeutic applications and specific formulations. The patent's value depends on its ability to withstand prior art scrutiny while maintaining enforceability across jurisdictions. Continuous monitoring of related patents is essential, considering the competitive biotech environment in South Korea and globally.
Key Takeaways
- The scope of KR20180122483 hinges on precise claim language covering compositions, methods, or uses, balancing broad protection with validity.
- Its patent landscape is shaped by domestic and international prior art, necessitating strategic patent drafting and aggressive prosecution.
- The strength of the patent depends on its ability to demonstrate novelty and inventive step over existing compounds and formulations.
- Stakeholders should closely analyze related patents and litigation history to evaluate risks and opportunities.
- Expanding patent protection internationally enhances market exclusivity, especially in major territories like the US, Europe, and China.
Frequently Asked Questions
1. How does KR20180122483 compare to international patents covering similar drugs?
Its scope depends on claim language and inventive distinctions over prior art. Cross-jurisdictional patent families may provide broader territorial protection if well-coordinated.
2. What are common challenges faced in defending pharmaceutical patents like KR20180122483?
Challenges include prior art invalidation, lack of inventive step, or claim indefiniteness. Patent examiners and litigants scrutinize claim novelty, clarity, and enforceability.
3. Can this patent be challenged or invalidated in South Korea?
Yes. Third parties can file oppositions or invalidation actions citing prior art or insufficiency if grounds exist.
4. How do claim drafting strategies influence the enforceability of pharmaceutical patents?
Precise, clear claims that balance breadth and specificity better withstand validity challenges and facilitate enforcement.
5. What is the significance of patent claims focusing on methods versus compositions?
Method claims protect processes and can be crucial where composition claims are narrow or vulnerable. Composition claims confer direct product exclusivity.
References
[1] South Korea Patent Office (KIPO) Patent Database, KR20180122483.
[2] WIPO PatentScope Database.
[3] European Patent Office (EPO) Worldwide Patent Statistical Database.
[4] R. M. Smith, Pharmaceutical Patent Law & Practice, 4th ed., 2020.
